What to watch. Sun Pharma: all eyes on buyback

Shares of Sun Pharmaceuticals will remain in focus, as the ₹675-crore buyback offer opens on Thursday. The company offers ₹900 a share to mop up 75 lakh shares from shareholders whose name appeared on its book, as on July 15. The offer will be on a proportionate basis. Sun Pharma had said the buyback aims to return surplus funds to investors. Promoters had indicated their intention to sell in the buyback but without altering their current shareholding status.